{"id":"W3030227576","doi":"10.1200/jco.2020.38.15_suppl.3073","title":"A signal-seeking trial of olaparib and durvalumab in homologous repair-deficient tumors: A sub-study of the cancer molecular screening and therapeutics (MoST) program.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Olaparib; Medicine; Cohort; Durvalumab; Internal medicine; Oncology; Clinical endpoint; Cancer; Surgery; Clinical trial; Immunotherapy; Nivolumab; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001698904,0.0008832234,0.001236059,0.0003522999,0.0002822802,0.0005212267,0.0005955331,0.0008268275,0.003550582],"category_scores_gemma":[0.0007146945,0.000293377,0.001025275,0.0002994259,0.0004973728,0.0005780207,0.000472431,0.001644616,0.0005561279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006808969,"about_ca_system_score_gemma":0.001061383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006040849,"about_ca_topic_score_gemma":0.001701598,"domain_scores_codex":[0.9995812,0.0002223039,0.00002128787,0.00006626097,0.00003532813,0.00007365838],"domain_scores_gemma":[0.9991904,0.0001686396,0.0001377826,0.00006220334,0.0000532687,0.0003876983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8682374,0.03388663,0.01095121,0.0005325216,0.001205794,0.0002601384,0.0001859393,0.001180618,0.02231554,0.0002093854,0.003259064,0.05777579],"study_design_scores_gemma":[0.6013238,0.3721963,0.01790761,0.00002496441,0.001018309,0.0003493796,0.00005410378,0.0009930552,0.003597,0.0001756252,0.002337852,0.00002190523],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995204,0.001041973,0.0001974284,0.0003110553,0.00004017571,0.001346525,0.0008276457,0.0000296655,0.001001486],"genre_scores_gemma":[0.991506,0.0008309729,0.00102197,0.0006579389,0.0001748674,0.001671027,0.002049197,0.00001612952,0.0020719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003550582,"threshold_uncertainty_score":0.01187789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1679972041619663,"score_gpt":0.4745135682877819,"score_spread":0.3065163641258156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}